Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials
The claimed invention provides a fusion polypeptide comprising a fibrous protein domain and a mineralization domain. The fusion is used to form an organic-inorganic composite. These organic-inorganic composites can be constructed from the nano- to the macro-scale depending on the size of the fibrous protein fusion domain used. In one embodiment, the composites can also be loaded with other compounds (e.g., dyes, drugs, enzymes) depending on the goal for the materials, to further enhance function. This can be achieved during assembly of the material or during the mineralization step in materials formation.
1. A method for forming a fibrous protein inorganic-composite comprising:
(a) contacting a fusion protein with an inorganic material capable of mineralizing for a sufficient period of time to allow mineralization of the inorganic material, wherein the fusion protein comprises a fibrous protein domain and a mineralizing domain, wherein the fibrous protein domain is obtained from silk and comprises a repeat unit as set forth in SEQ ID NO: 1 or SEQ ID NO: 3, and wherein the mineralizing domain is capable of inducing mineralization and wherein the mineralizing domain is obtained from bone sialoprotein (BSP), silaffin-1(Sil1) protein, or functional fragments thereof.
2. The method of claim 1 , wherein the fibrous protein domain is from the silk protein Spidroin 1.
3. The method of claim 1 , wherein the fibrous protein domain comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 4 and 5.
4. The method of claim 1 , wherein the mineralizing domain induces the formation of hydroxyapatite, silica, cadmium sulfide or magnetite.
5. The method of claim 1 , wherein the mineralization domain comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 8 and 17-23.
6. The method of claim 1 , wherein the fusion protein comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 11, 12, 24, and 25.
7. The method of claim 1 , wherein the inorganic material forms hydroxyapatite or silica.
8. The method of claim 1 , wherein the fusion protein comprises a fiber, a film, or a sponge.
9. The method of claim 8 , wherein the fiber, film, or sponge further comprises an agent.
10. The method of claim 9 , wherein the agent is selected from the group consisting of a protein, peptide, nucleic acid, PNA, aptamer, antibody and a small molecule.
11. A fusion polypeptide comprising a fibrous protein domain and a mineralizing domain, wherein the fibrous protein domain is obtained from silk and comprises a repeat unit as set forth in SEQ ID NO: 1 or SEQ ID NO: 3, and wherein the mineralizing domain is capable of inducing mineralization and wherein the mineralizing domain is obtained from bone sialoprotein (BSP), silaffin-1 (Sil1) protein and functional fragments thereof.
12. The fusion polypeptide of claim 11 , wherein the fibrous protein domain is from the silk protein Spidroin 1.
13. The fusion polypeptide of claim 11 , wherein the fibrous protein domain comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 4 and 5.
14. The fusion polypeptide of claim 11 , wherein the mineralizing domain induces the formation of hydroxyapatite, silica, cadmium sulfide or magnetite.
15. The fusion polypeptide of claim 11 , wherein the mineralization domain comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 8 and 17-23.
16. The fusion polypeptide of claim 11 , wherein the fusion protein comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 11, 12, 24, and 25.
17. The fusion polypeptide of claim 11 , wherein the fusion polypeptide comprises a fiber, a film, or a sponge.
18. The fusion polypeptide of claim 17 , wherein the fiber, film, or sponge further comprises an agent.
19. The fusion polypeptide of claim 18 , wherein the agent is selected from the group consisting of a protein, peptide, nucleic acid, PNA, aptamer, antibody and a small molecule.